Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement

BACKGROUND—Paravalvular regurgitation (PVR) is common after transcatheter aortic valve replacement (TAVR) and may be associated with adverse outcomes. Postdilatation (PD) has been proposed to treat PVR without being formally studied. We performed a study to evaluate the safety and efficacy of PD aft...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Cardiovascular interventions 2013-02, Vol.6 (1), p.85-91
Hauptverfasser: Daneault, Benoit, Koss, Elana, Hahn, Rebecca T, Kodali, Susheel, Williams, Mathew R, Généreux, Philippe, Paradis, Jean-Michel, George, Isaac, Reiss, George R, Moses, Jeffrey W, Smith, Craig R, Leon, Martin B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 91
container_issue 1
container_start_page 85
container_title Circulation. Cardiovascular interventions
container_volume 6
creator Daneault, Benoit
Koss, Elana
Hahn, Rebecca T
Kodali, Susheel
Williams, Mathew R
Généreux, Philippe
Paradis, Jean-Michel
George, Isaac
Reiss, George R
Moses, Jeffrey W
Smith, Craig R
Leon, Martin B
description BACKGROUND—Paravalvular regurgitation (PVR) is common after transcatheter aortic valve replacement (TAVR) and may be associated with adverse outcomes. Postdilatation (PD) has been proposed to treat PVR without being formally studied. We performed a study to evaluate the safety and efficacy of PD after balloon expandable TAVR. METHODS AND RESULTS—Consecutive cases of TAVR were reviewed for clinical outcomes. Procedural transesophageal echocardiography imaging was reviewed for a subgroup of consecutive patients. PVR areas seen on a short-axis view were measured immediately after deployment, after PD, and at the completion of the study. Stent dimensions measured using angiography and the Paieon’s C-THV system pre- and post-PD were compared. Between May 2007 and November 2011, 259 patients underwent TAVR at our institution. PD was performed in 106 patients (41%). These patients had larger annulus, lower cover-index; more often had transfemoral access and implantation of a 26 mm valve. There was a nonsignificant greater rate of cerebrovascular events in PD patients. There was no significant difference in major aortic injury and permanent pacemaker implantation rates between groups. TTE studies were reviewed in 58 patients (35 with PD and 23 without PD). PD patients had larger PVR areas immediately after deployment (40.3±17.1 versus 15.4±14.2 mm; P
doi_str_mv 10.1161/CIRCINTERVENTIONS.112.971614
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1291598731</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1291598731</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4884-d131fd510830d156fb897133ecf0eea56c4fa1fbf43dcd9daa351864c35dd8c43</originalsourceid><addsrcrecordid>eNplkcFuEzEQhi0EoqXwCsgHDly22GvvZlfiUsJSIlVplYZerYk9ThacdWp7W_IMfWmMEnrhYHn0-5_PmvkJ-cDZOec1_zSdLaaz-bJb3HXz5ex6fpvl8ryd5Df5gpzyVvJiUovy5XMt2Ql5E-NPxrJcl6_JSSmEaBvJT8lTZ22vQe8pDIbegsW0p97SGx-T6R0kSL0faPJ0gWbUSG8gwAO4h9FByNp6DOv-aPo6hn5Y0y_gnPdD0f3eZSasHNJlgCFqSBtMGOiFD6nX9C5TMCN2DjRucUhvySsLLuK7431GfnzrltPvxdX15Wx6cVVo2TSyMFxwayrOGsEMr2q7avL0QqC2DBGqWksL3K6sFEab1gCIije11KIyptFSnJGPB-4u-PsRY1LbPmp0Dgb0Y1S8bHnVNhPBs_XzwaqDjzGgVbvQbyHsFWfqbxzqvziyXKpDHLn9_fGncbVF89z8b__ZIA-GR-_yauIvNz5iUBsElzaK5akmsq2KMlesZIwV-WTuHxHLm-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1291598731</pqid></control><display><type>article</type><title>Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Daneault, Benoit ; Koss, Elana ; Hahn, Rebecca T ; Kodali, Susheel ; Williams, Mathew R ; Généreux, Philippe ; Paradis, Jean-Michel ; George, Isaac ; Reiss, George R ; Moses, Jeffrey W ; Smith, Craig R ; Leon, Martin B</creator><creatorcontrib>Daneault, Benoit ; Koss, Elana ; Hahn, Rebecca T ; Kodali, Susheel ; Williams, Mathew R ; Généreux, Philippe ; Paradis, Jean-Michel ; George, Isaac ; Reiss, George R ; Moses, Jeffrey W ; Smith, Craig R ; Leon, Martin B</creatorcontrib><description>BACKGROUND—Paravalvular regurgitation (PVR) is common after transcatheter aortic valve replacement (TAVR) and may be associated with adverse outcomes. Postdilatation (PD) has been proposed to treat PVR without being formally studied. We performed a study to evaluate the safety and efficacy of PD after balloon expandable TAVR. METHODS AND RESULTS—Consecutive cases of TAVR were reviewed for clinical outcomes. Procedural transesophageal echocardiography imaging was reviewed for a subgroup of consecutive patients. PVR areas seen on a short-axis view were measured immediately after deployment, after PD, and at the completion of the study. Stent dimensions measured using angiography and the Paieon’s C-THV system pre- and post-PD were compared. Between May 2007 and November 2011, 259 patients underwent TAVR at our institution. PD was performed in 106 patients (41%). These patients had larger annulus, lower cover-index; more often had transfemoral access and implantation of a 26 mm valve. There was a nonsignificant greater rate of cerebrovascular events in PD patients. There was no significant difference in major aortic injury and permanent pacemaker implantation rates between groups. TTE studies were reviewed in 58 patients (35 with PD and 23 without PD). PD patients had larger PVR areas immediately after deployment (40.3±17.1 versus 15.4±14.2 mm; P&lt;0.0001). There was significant reduction in PVR area attributable to PD (21.7±9.3 mm; P&lt;0.0001). Spontaneous regression of PVR was seen in both groups. PD increased stent dimensions. CONCLUSIONS—This study demonstrates the efficacy of PD at reducing PVR in patients with greater than mild PVR after balloon-expandable TAVR.</description><identifier>ISSN: 1941-7640</identifier><identifier>EISSN: 1941-7632</identifier><identifier>DOI: 10.1161/CIRCINTERVENTIONS.112.971614</identifier><identifier>PMID: 23339841</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Aged ; Aged, 80 and over ; Angioplasty, Balloon - methods ; Aortic Valve - pathology ; Aortic Valve - surgery ; Aortic Valve Stenosis - surgery ; Cardiac Catheterization ; Female ; Heart Valve Prosthesis Implantation ; Humans ; Male ; Mitral Valve Insufficiency - etiology ; Mitral Valve Insufficiency - prevention &amp; control ; Postoperative Complications - prevention &amp; control ; Survival Analysis ; Treatment Outcome</subject><ispartof>Circulation. Cardiovascular interventions, 2013-02, Vol.6 (1), p.85-91</ispartof><rights>2013 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4884-d131fd510830d156fb897133ecf0eea56c4fa1fbf43dcd9daa351864c35dd8c43</citedby><cites>FETCH-LOGICAL-c4884-d131fd510830d156fb897133ecf0eea56c4fa1fbf43dcd9daa351864c35dd8c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23339841$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daneault, Benoit</creatorcontrib><creatorcontrib>Koss, Elana</creatorcontrib><creatorcontrib>Hahn, Rebecca T</creatorcontrib><creatorcontrib>Kodali, Susheel</creatorcontrib><creatorcontrib>Williams, Mathew R</creatorcontrib><creatorcontrib>Généreux, Philippe</creatorcontrib><creatorcontrib>Paradis, Jean-Michel</creatorcontrib><creatorcontrib>George, Isaac</creatorcontrib><creatorcontrib>Reiss, George R</creatorcontrib><creatorcontrib>Moses, Jeffrey W</creatorcontrib><creatorcontrib>Smith, Craig R</creatorcontrib><creatorcontrib>Leon, Martin B</creatorcontrib><title>Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement</title><title>Circulation. Cardiovascular interventions</title><addtitle>Circ Cardiovasc Interv</addtitle><description>BACKGROUND—Paravalvular regurgitation (PVR) is common after transcatheter aortic valve replacement (TAVR) and may be associated with adverse outcomes. Postdilatation (PD) has been proposed to treat PVR without being formally studied. We performed a study to evaluate the safety and efficacy of PD after balloon expandable TAVR. METHODS AND RESULTS—Consecutive cases of TAVR were reviewed for clinical outcomes. Procedural transesophageal echocardiography imaging was reviewed for a subgroup of consecutive patients. PVR areas seen on a short-axis view were measured immediately after deployment, after PD, and at the completion of the study. Stent dimensions measured using angiography and the Paieon’s C-THV system pre- and post-PD were compared. Between May 2007 and November 2011, 259 patients underwent TAVR at our institution. PD was performed in 106 patients (41%). These patients had larger annulus, lower cover-index; more often had transfemoral access and implantation of a 26 mm valve. There was a nonsignificant greater rate of cerebrovascular events in PD patients. There was no significant difference in major aortic injury and permanent pacemaker implantation rates between groups. TTE studies were reviewed in 58 patients (35 with PD and 23 without PD). PD patients had larger PVR areas immediately after deployment (40.3±17.1 versus 15.4±14.2 mm; P&lt;0.0001). There was significant reduction in PVR area attributable to PD (21.7±9.3 mm; P&lt;0.0001). Spontaneous regression of PVR was seen in both groups. PD increased stent dimensions. CONCLUSIONS—This study demonstrates the efficacy of PD at reducing PVR in patients with greater than mild PVR after balloon-expandable TAVR.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angioplasty, Balloon - methods</subject><subject>Aortic Valve - pathology</subject><subject>Aortic Valve - surgery</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Cardiac Catheterization</subject><subject>Female</subject><subject>Heart Valve Prosthesis Implantation</subject><subject>Humans</subject><subject>Male</subject><subject>Mitral Valve Insufficiency - etiology</subject><subject>Mitral Valve Insufficiency - prevention &amp; control</subject><subject>Postoperative Complications - prevention &amp; control</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>1941-7640</issn><issn>1941-7632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkcFuEzEQhi0EoqXwCsgHDly22GvvZlfiUsJSIlVplYZerYk9ThacdWp7W_IMfWmMEnrhYHn0-5_PmvkJ-cDZOec1_zSdLaaz-bJb3HXz5ex6fpvl8ryd5Df5gpzyVvJiUovy5XMt2Ql5E-NPxrJcl6_JSSmEaBvJT8lTZ22vQe8pDIbegsW0p97SGx-T6R0kSL0faPJ0gWbUSG8gwAO4h9FByNp6DOv-aPo6hn5Y0y_gnPdD0f3eZSasHNJlgCFqSBtMGOiFD6nX9C5TMCN2DjRucUhvySsLLuK7431GfnzrltPvxdX15Wx6cVVo2TSyMFxwayrOGsEMr2q7avL0QqC2DBGqWksL3K6sFEab1gCIije11KIyptFSnJGPB-4u-PsRY1LbPmp0Dgb0Y1S8bHnVNhPBs_XzwaqDjzGgVbvQbyHsFWfqbxzqvziyXKpDHLn9_fGncbVF89z8b__ZIA-GR-_yauIvNz5iUBsElzaK5akmsq2KMlesZIwV-WTuHxHLm-o</recordid><startdate>201302</startdate><enddate>201302</enddate><creator>Daneault, Benoit</creator><creator>Koss, Elana</creator><creator>Hahn, Rebecca T</creator><creator>Kodali, Susheel</creator><creator>Williams, Mathew R</creator><creator>Généreux, Philippe</creator><creator>Paradis, Jean-Michel</creator><creator>George, Isaac</creator><creator>Reiss, George R</creator><creator>Moses, Jeffrey W</creator><creator>Smith, Craig R</creator><creator>Leon, Martin B</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201302</creationdate><title>Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement</title><author>Daneault, Benoit ; Koss, Elana ; Hahn, Rebecca T ; Kodali, Susheel ; Williams, Mathew R ; Généreux, Philippe ; Paradis, Jean-Michel ; George, Isaac ; Reiss, George R ; Moses, Jeffrey W ; Smith, Craig R ; Leon, Martin B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4884-d131fd510830d156fb897133ecf0eea56c4fa1fbf43dcd9daa351864c35dd8c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angioplasty, Balloon - methods</topic><topic>Aortic Valve - pathology</topic><topic>Aortic Valve - surgery</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Cardiac Catheterization</topic><topic>Female</topic><topic>Heart Valve Prosthesis Implantation</topic><topic>Humans</topic><topic>Male</topic><topic>Mitral Valve Insufficiency - etiology</topic><topic>Mitral Valve Insufficiency - prevention &amp; control</topic><topic>Postoperative Complications - prevention &amp; control</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daneault, Benoit</creatorcontrib><creatorcontrib>Koss, Elana</creatorcontrib><creatorcontrib>Hahn, Rebecca T</creatorcontrib><creatorcontrib>Kodali, Susheel</creatorcontrib><creatorcontrib>Williams, Mathew R</creatorcontrib><creatorcontrib>Généreux, Philippe</creatorcontrib><creatorcontrib>Paradis, Jean-Michel</creatorcontrib><creatorcontrib>George, Isaac</creatorcontrib><creatorcontrib>Reiss, George R</creatorcontrib><creatorcontrib>Moses, Jeffrey W</creatorcontrib><creatorcontrib>Smith, Craig R</creatorcontrib><creatorcontrib>Leon, Martin B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation. Cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daneault, Benoit</au><au>Koss, Elana</au><au>Hahn, Rebecca T</au><au>Kodali, Susheel</au><au>Williams, Mathew R</au><au>Généreux, Philippe</au><au>Paradis, Jean-Michel</au><au>George, Isaac</au><au>Reiss, George R</au><au>Moses, Jeffrey W</au><au>Smith, Craig R</au><au>Leon, Martin B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement</atitle><jtitle>Circulation. Cardiovascular interventions</jtitle><addtitle>Circ Cardiovasc Interv</addtitle><date>2013-02</date><risdate>2013</risdate><volume>6</volume><issue>1</issue><spage>85</spage><epage>91</epage><pages>85-91</pages><issn>1941-7640</issn><eissn>1941-7632</eissn><abstract>BACKGROUND—Paravalvular regurgitation (PVR) is common after transcatheter aortic valve replacement (TAVR) and may be associated with adverse outcomes. Postdilatation (PD) has been proposed to treat PVR without being formally studied. We performed a study to evaluate the safety and efficacy of PD after balloon expandable TAVR. METHODS AND RESULTS—Consecutive cases of TAVR were reviewed for clinical outcomes. Procedural transesophageal echocardiography imaging was reviewed for a subgroup of consecutive patients. PVR areas seen on a short-axis view were measured immediately after deployment, after PD, and at the completion of the study. Stent dimensions measured using angiography and the Paieon’s C-THV system pre- and post-PD were compared. Between May 2007 and November 2011, 259 patients underwent TAVR at our institution. PD was performed in 106 patients (41%). These patients had larger annulus, lower cover-index; more often had transfemoral access and implantation of a 26 mm valve. There was a nonsignificant greater rate of cerebrovascular events in PD patients. There was no significant difference in major aortic injury and permanent pacemaker implantation rates between groups. TTE studies were reviewed in 58 patients (35 with PD and 23 without PD). PD patients had larger PVR areas immediately after deployment (40.3±17.1 versus 15.4±14.2 mm; P&lt;0.0001). There was significant reduction in PVR area attributable to PD (21.7±9.3 mm; P&lt;0.0001). Spontaneous regression of PVR was seen in both groups. PD increased stent dimensions. CONCLUSIONS—This study demonstrates the efficacy of PD at reducing PVR in patients with greater than mild PVR after balloon-expandable TAVR.</abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>23339841</pmid><doi>10.1161/CIRCINTERVENTIONS.112.971614</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1941-7640
ispartof Circulation. Cardiovascular interventions, 2013-02, Vol.6 (1), p.85-91
issn 1941-7640
1941-7632
language eng
recordid cdi_proquest_miscellaneous_1291598731
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Aged
Aged, 80 and over
Angioplasty, Balloon - methods
Aortic Valve - pathology
Aortic Valve - surgery
Aortic Valve Stenosis - surgery
Cardiac Catheterization
Female
Heart Valve Prosthesis Implantation
Humans
Male
Mitral Valve Insufficiency - etiology
Mitral Valve Insufficiency - prevention & control
Postoperative Complications - prevention & control
Survival Analysis
Treatment Outcome
title Efficacy and Safety of Postdilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T11%3A33%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20Safety%20of%20Postdilatation%20to%20Reduce%20Paravalvular%20Regurgitation%20During%20Balloon-Expandable%20Transcatheter%20Aortic%20Valve%20Replacement&rft.jtitle=Circulation.%20Cardiovascular%20interventions&rft.au=Daneault,%20Benoit&rft.date=2013-02&rft.volume=6&rft.issue=1&rft.spage=85&rft.epage=91&rft.pages=85-91&rft.issn=1941-7640&rft.eissn=1941-7632&rft_id=info:doi/10.1161/CIRCINTERVENTIONS.112.971614&rft_dat=%3Cproquest_cross%3E1291598731%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1291598731&rft_id=info:pmid/23339841&rfr_iscdi=true